Q2 2023 Getinge AB Earnings Call Transcript
Welcome to the Getinge AB Q2 presentation for 2023. (Operator Instructions) Now I will hand the conference over to CEO, Mattias Perjos; and CFO, Lars Sandström. Please go ahead.
()- -
Hi, everyone, and welcome to today's conference. This is Mattias Perjos, and I'm accompanied by our CFO, Lars Sandström, as well. We can move directly over to Page #2, please.
So if we start with the summary and the key takeaways for the quarter, Getinge's sales increased organically by 1.3% during the quarter due to the strong performance of Surgical Workflows, while we had order intake drop 4.5%, mostly driven by the quality and supply chain challenges that we see in Cardiac Assist, plus some market weakness in the bioprocessing part of Life Science.
The group sales, margins and cash flow were negatively impacted by these challenges as well in Cardiac Assist and Cardiopulmonary in our Acute Care Therapies business area, and this is something that we've
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
